Literature DB >> 9120476

Increase of flexor reflex latency in patients with amyotrophic lateral sclerosis treated with riluzole.

M W Riepe, G Klappenbach, A C Ludolph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9120476      PMCID： PMC1074119          DOI： 10.1136/jnnp.62.4.427

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

2.  Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

Authors:  M W Debono; J Le Guern; T Canton; A Doble; L Pradier
Journal:  Eur J Pharmacol       Date:  1993-04-28       Impact factor: 4.432

3.  Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate.

Authors:  P J Shaw; R M Chinnery; P G Ince
Journal:  Brain Res       Date:  1994-08-29       Impact factor: 3.252

4.  Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice.

Authors:  L Turski; K Bressler; T Klockgether; D N Stephens
Journal:  Neurosci Lett       Date:  1990-05-18       Impact factor: 3.046
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.